References
- Passarello K, Kurian S, Villanueva V. Endometrial cancer: an overview of pathophysiology, management, and care. Semin Oncol Nurs. 2019;35(2):1–7. doi: 10.1016/j.soncn.2019.02.002.
- Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi: 10.3322/caac.21708.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi: 10.3322/caac.21442.
- Suarez AA, Felix AS, Cohn DE. Bokhman redux: endometrial cancer “types” in the 21st century. Gynecol Oncol. 2017;144(2):243–249. doi: 10.1016/j.ygyno.2016.12.010.
- Rodriguez AC, Blanchard Z, Maurer KA, et al. Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions. Horm Cancer. 2019;10(2-3):51–63. doi: 10.1007/s12672-019-0358-9.
- Setiawan VW, Yang HP, Pike MC, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31(20):2607–2618. doi: 10.1200/JCO.2012.48.2596.
- Groothuis PG, Dassen HH, Romano A, et al. Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human. Hum Reprod Update. 2007;13(4):405–417. doi: 10.1093/humupd/dmm009.
- Yang CH, Almomen A, Wee YS, et al. An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations. Cancer Med. 2015;4(7):1039–1050. doi: 10.1002/cam4.445.
- Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer. 2003;10(1):23–42. doi: 10.1677/erc.0.0100023.
- Gutschner T, Diederichs S. The hallmarks of cancer: a long noncoding RNA point of view. RNA Biol. 2012;9(6):703–719. doi: 10.4161/rna.20481.
- Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–1323. doi: 10.1016/j.cell.2007.05.022.
- Yuan C, Ning Y, Pan Y. Emerging roles of HOTAIR in human cancer. J Cell Biochem. 2020;121(5-6):3235–3247. doi: 10.1002/jcb.29591.
- Liu Y, Chen X, Chen X, et al. Long noncoding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer. Cell Death Dis. 2020;11(3):175. doi: 10.1038/s41419-020-2268-8.
- Salmeron-Barcenas EG, Illades-Aguiar B, Del Moral-Hernandez O, et al. HOTAIR knockdown decreased the activity wnt/beta-Catenin signaling pathway and increased the mRNA levels of its negative regulators in hela cells. Cell Physiol Biochem. 2019;53(6):948–960.
- Song Y, Wang R, Li LW, et al. Long noncoding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer. Int J Oncol. 2019;54(1):77–86. doi: 10.3892/ijo.2018.4625.
- Xue M, Chen LY, Wang WJ, et al. HOTAIR induces the ubiquitination of Runx3 by interacting with Mex3b and enhances the invasion of gastric cancer cells. Gastric Cancer. 2018;21(5):756–764. doi: 10.1007/s10120-018-0801-6.
- Gupta RA, Shah N, Wang KC, et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076. doi: 10.1038/nature08975.
- Huang J, Ke P, Guo L, et al. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int J Gynecol Cancer. 2014;24(4):635–642. doi: 10.1097/IGC.0000000000000121.
- Zhang XH, Hu P, Xie YQ, et al. Long noncoding RNA HOTAIR promotes endometrial carcinoma cell proliferation by binding to PTEN via the activating phosphatidylinositol 3-Kinase/akt signaling pathway. Mol Cell Biol. 2019;39(23):e00251–19. doi: 10.1128/MCB.00251-19.
- Zhou YX, Wang C, Mao LW, et al. Long noncoding RNA HOTAIR mediates the estrogen-induced metastasis of endometrial cancer cells via the miR-646/NPM1 axis. Am J Physiol Cell Physiol. 2018;314(6):C690–C701. doi: 10.1152/ajpcell.00222.2017.
- Sharma D, Kumar S, Narasimhan B. Estrogen alpha receptor antagonists for the treatment of breast cancer: a review. Chem Cent J. 2018;12(1):107. doi: 10.1186/s13065-018-0472-8.
- Janacova L, Faktor J, Capkova L, et al. SWATH-MS analysis of FFPE tissues identifies stathmin as a potential marker of endometrial cancer in patients exposed to tamoxifen. J Proteome Res. 2020;19(7):2617–2630. doi: 10.1021/acs.jproteome.0c00064.
- Li BL, Wan XP. The role of lncRNAs in the development of endometrial carcinoma. Oncol Lett. 2018;16(3):3424–3429. doi: 10.3892/ol.2018.9065.
- Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–17. doi: 10.1016/0090-8258(83)90111-7.
- Bhan A, Hussain I, Ansari KI, et al. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol Biol. 2013;425(19):3707–3722. doi: 10.1016/j.jmb.2013.01.022.
- Liu X, Liu X. PRC2, chromatin regulation, and human disease: insights from molecular structure and function. Front Oncol. 2022;12:894585. doi: 10.3389/fonc.2022.894585.
- Fang X, Ni N, Wang X, et al. EZH2 and endometrial cancer development: insights from a mouse model. Cells. 2022;11(5):909. doi: 10.3390/cells11050909.
- Portoso M, Ragazzini R, Brencic Z, et al. PRC2 is dispensable for HOTAIR-mediated transcriptional repression. Embo J. 2017;36(8):981–994. doi: 10.15252/embj.201695335.